BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 1669702)

  • 21. Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs.
    Steinbach K; Piedavent M; Bauer S; Neumann JT; Friese MA
    J Immunol; 2013 Nov; 191(9):4531-9. PubMed ID: 24062488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T lymphocytes promote the development of bone marrow-derived APC in the central nervous system.
    Subramanian S; Bourdette DN; Corless C; Vandenbark AA; Offner H; Jones RE
    J Immunol; 2001 Jan; 166(1):370-6. PubMed ID: 11123314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do not judge a cell by its cover--diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation.
    Brendecke SM; Prinz M
    Semin Immunopathol; 2015 Nov; 37(6):591-605. PubMed ID: 26251238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient.
    Phares TW; Fabis MJ; Brimer CM; Kean RB; Hooper DC
    J Immunol; 2007 Jun; 178(11):7334-43. PubMed ID: 17513784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of adhesion molecules and histocompatibility antigens at the blood-brain barrier.
    Lassmann H; Rössler K; Zimprich F; Vass K
    Brain Pathol; 1991 Jan; 1(2):115-23. PubMed ID: 1669697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.
    Pedemonte E; Mancardi G; Giunti D; Corcione A; Benvenuto F; Pistoia V; Uccelli A
    Pharmacol Ther; 2006 Sep; 111(3):555-66. PubMed ID: 16442633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte traffic in the central nervous system: the participants and their roles.
    Hickey WF
    Semin Immunol; 1999 Apr; 11(2):125-37. PubMed ID: 10329499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo.
    Hickey WF; Kimura H
    Science; 1988 Jan; 239(4837):290-2. PubMed ID: 3276004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
    Zheng H; Zhang H; Liu F; Qi Y; Jiang H
    Immunol Lett; 2014; 157(1-2):38-44. PubMed ID: 24220208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell trafficking competence is required for CNS invasion.
    Lees JR; Archambault AS; Russell JH
    J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma delta T cell regulation of IFN-gamma production by central nervous system-infiltrating encephalitogenic T cells: correlation with recovery from experimental autoimmune encephalomyelitis.
    Ponomarev ED; Novikova M; Yassai M; Szczepanik M; Gorski J; Dittel BN
    J Immunol; 2004 Aug; 173(3):1587-95. PubMed ID: 15265886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma delta T cells regulate the extent and duration of inflammation in the central nervous system by a Fas ligand-dependent mechanism.
    Ponomarev ED; Dittel BN
    J Immunol; 2005 Apr; 174(8):4678-87. PubMed ID: 15814692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cells in multiple sclerosis and inflammatory central nervous system diseases.
    Hafler DA; Weiner HL
    Immunol Rev; 1987 Dec; 100():307-32. PubMed ID: 3326824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
    Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
    J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune disease in the brain--how to spot the culprits and how to keep them in check.
    Flügel A; Schläger C; Lühder F; Odoardi F
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S3-11. PubMed ID: 22206764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three or more routes for leukocyte migration into the central nervous system.
    Ransohoff RM; Kivisäkk P; Kidd G
    Nat Rev Immunol; 2003 Jul; 3(7):569-81. PubMed ID: 12876559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Innate Immune Receptor CD14 Mediates Lymphocyte Migration in EAE.
    Halmer R; Davies L; Liu Y; Fassbender K; Walter S
    Cell Physiol Biochem; 2015; 37(1):269-75. PubMed ID: 26302995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Elieh-Ali-Komi D; Cao Y
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CNS: Not an immunoprivilaged site anymore but a virtual secondary lymphoid organ.
    Negi N; Das BK
    Int Rev Immunol; 2018 Jan; 37(1):57-68. PubMed ID: 28961037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of IL-17 in CNS diseases.
    Waisman A; Hauptmann J; Regen T
    Acta Neuropathol; 2015 May; 129(5):625-37. PubMed ID: 25716179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.